Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RBP4 | P02753 | 1/20 | 0.37 |
| ▸ | TARDBP | Q13148 | 1/20 | 0.37 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | FFAR2 | O15552 | 3/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | VNN1 | O95497 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL31705742 | 0.88 | TARDBP (0.36) | TARDBPFFAR2CHRM2CHRM3LRRK2 | |
| Lithium Ion SCHEMBL31705051 | 0.88 | TARDBP (0.36) | TARDBPFFAR2CHRM2CHRM3LRRK2 | |
| SCHEMBL31705022 | 0.85 | CRBN (0.39) | TARDBPFFAR2CHRM2CHRM3LRRK2 | |
| SCHEMBL4821896 | 0.79 | KMO (0.55) | RBP4KMOPIM2POLB | |
| SCHEMBL6756872 | 0.74 | RBP4 (0.44) | RBP4TARDBPKMOPIM2POLB | |
| SCHEMBL31301445 | 0.73 | RBP4 (0.43) | RBP4TARDBP | |
| SCHEMBL25339860 | 0.72 | APOBEC3A (0.38) | KMOFFAR2LRRK2 | |
| SCHEMBL10367486 | 0.72 | PIM2 (0.45) | RBP4TARDBPPIM2POLB | |
| SCHEMBL25339027 | 0.71 | SMPD3 (0.44) | — | |
| SCHEMBL31078509 | 0.70 | PIM2 (0.47) | RBP4PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215110-A1 | NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS | LES LABORATOIRES SERVIER (FR) | 2025-10-16 | — | — | WO | disclosed |